ABSTRACT. The expression of phospholipase D (PLD) isozymes was examined in the hearts of rats at different stages of development. Immunoprecipitation and Western blot analysis revealed weak PLD1 expression in the hearts of day 17 embryos. The level of PLD1 protein increased transiently 0 and 3 days postpartum, and declined gradually beginning 7 days after birth. Immunohistochemistry revealed weak PLD1 immunostaining in some cells at embryonic day 17. In contrast, some vascular endothelial cells and cardiomyocytes were immunostained typically at days 0, 3, and 7 after birth. After postnatal day 21, weak PLD1 expression was immunodetected in some vascular endothelial cells and cardiomyocytes. This suggests that the PLD1 protein in the heart is strongly associated with the early postnatal development of the heart in rats. KEY WORDS: development, heart, phospholipase D1.
Phospholipase D (PLD) hydrolyzes phosphatidylcholine to phosphatidic acid (PA) and choline [13] . PA acts as a second messenger and can be converted into other messenger molecules, such as 1,2-diacylglycerol (DG) and lysophosphatidic acid [13] . PLD isozymes, including PLD1 and PLD2, are ubiquitous in all mammalian tissues [10] and regulate a wide variety of cellular processes, including cell differentiation [11] , proliferation [1] , and apoptosis [13] . PLD1 has low basal activity and is activated in vitro by ADP ribosylation factor, Rho family GTP-binding proteins (G proteins), and protein kinase C (PKC) in the presence of phosphatidylinositol 4,5-bisphosphate, whereas PLD2 has very high basal activity and is unresponsive to small G proteins and PKC [3] . In vivo, PLD1 and PLD2 are expressed differently in a variety of normal adult mouse tissues, suggesting that each PLD isozyme plays a distinct role in each organ [6] .
The growth of the heart during perinatal states is characterized by myocardial cell hyperplasia [9, 14] . Further growth of the heart is due to myocyte hypertrophy and nonmuscle cell hyperplasia [14] . These change with the expression of contractile proteins, as well as the regulation of intracellular signal transduction proteins, such as second messenger-and cyclin-dependent protein kinases [7] , PKC [16, 17] , PLC [4] , and G protein [4] ; these proteins were found to be downregulated concurrently during development. Based on previous studies showing that PLD is strongly associated with cell differentiation after birth [12] and that PA, which is a product of PLD, is involved in augmenting the cardiac contractile activity of the normal heart [19] , PLD might be involved in the early growth of the heart. In addition, it was recently reported that both PLD1 and PLD2 expressions are enhanced in rats with cardiac hypertrophy [15] . However, little is known about the pattern of PLD1 expression in the hearts of laboratory animals, including rats, according to the level of postnatal development.
In this regard, this study investigated the expression patterns and cellular localization of PLD1 as it relates to cardiac function during postnatal development of the rat heart using Western blotting and immunohistochemistry.
Sprague-Dawley rats (Orient Bio, Gyunggi-do, Korea) of both genders were maintained in the laboratory. After mating, the ventricles of hearts (6 samples/time point) were sampled at embryonic day 17 and postnatal days 0, 3, 7, 21, 35, and 49, and examined using Western blotting and histological analyses. All the experiments were carried out in accordance with the National Research Council's Guide for the Care and Use of Laboratory Animals (Korea).
Rabbit polyclonal antibody was generated to a peptide consisting of the 12 C-terminal amino acids of PLD1; this also recognizes PLD2 because 7 of the 12 amino acids of the PLD1 C-terminal region are the same as those in PLD2 [6] .
For Western blot analysis, heart tissues were dissected and lysed in a lysis buffer [20 mM HEPES (pH 7.2), 1% Triton X-100, 1% deoxycholate, 0.1% SDS, 150 mM NaCl, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM phenylmethylsulfonylfluoride].
The immunoprecipitation method and Western blot analysis were described in a previous paper [6] . Briefly, the supernatant of the lysates of the heart tissues was precleared by incubation with preimmune IgG and protein ASepharose for 30 min. The precleared cell lysates were incubated with the anti-PLD antibody and 30 µl of a 50% slurry of protein A-Sepharose for 4 hr. The immune complex was collected by centrifugation and washed five times with an ice-cold buffer containing 20 mM Tris (pH 7.5), 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 2 mM Na 3 VO 4 , 10% glycerol, and 1% Nonidet P-40. SDS sample buffer was added, and the mixture was boiled. The recovered proteins were separated using SDS-polyacrylamide gel electrophoresis. Then, the separated proteins were transferred to a PVDF membrane (Immobilon-P; Millipore, Billerica, MA, U.S.A.), blocked in 5% nonfat dried milk, and probed with the anti-PLD antibody as indicated. The immunoreactive bands were visualized by chemiluminescence using horseradish peroxidase-conjugated secondary antibodies and the ECL reagents (Amersham Biosciences, Piscataway, NJ, U.S.A.).
Pieces of heart were fixed in 4% paraformaldehyde in phosphate buffer and embedded in paraffin. The paraffin sections were stained with hematoxylin and eosin, and used for immunohistochemistry.
Immunohistochemical staining was performed, with slight modifications, in the manner of our previous study [6] . In brief, 5-µm sections of paraffin-embedded heart were deparaffinized and incubated with the affinity-purified rabbit anti-PLD antibody. The immunoreactions were visualized using avidin-biotin peroxidase complexes (Elite kit; Vector, Burlingame, CA, U.S.A.), and the peroxidase reaction was developed using a diaminobenzidine substrate kit (Vector).
The pattern of PLD isozyme expression during development of the rat heart was investigated using rabbit polyclonal antibody to PLD. As shown in Fig. 1 , weak PLD1 expression was detected in the heart at embryonic day 17. Its expression subsequently increased and peaked at days 0 and 3 after birth (an approximately 7-fold increase at postnatal days 0 and 3 compared to that at embryonic day 17 according to the densitometry analysis). At postnatal day 7, the level of PLD1 expression decreased to the level observed at embryonic day 17 ( Fig. 1) . At postnatal day 21, PLD immunoreactivity was very weakly detected, and thereafter, the expression of PLD1 in the heart was virtually undetectable using the current immunoprecipitation method. In contrast, PLD2 was not detected by the antibody to PLD1/2, which recognizes both PLD1 and PLD2, suggesting that PLD1, but not PLD2, is the major PLD isozyme involved in the natal and postnatal development of the rat heart.
At embryonic day 17, weak PLD1 immunostaining was observed in some cardiomyocytes ( Fig. 2A) . At postnatal day 3, many dividing or divided cardiomyocytes were observed in the heart. PLD1 immunoreactivity was visualized in some dividing and divided cardiomyocytes and vessels (Fig. 2B) . By postnatal day 21, the size of the cardiomyocytes had increased gradually compared to that observed at postnatal day 3. Diffuse immunostaining for PLD1 was seen in some cardiomyocytes (Fig. 2C) . Moreover, at postnatal day 49, the size of the cardiomyocytes had increased further compared to that observed at postnatal day 21; some of these cells were positive for PLD (Fig. 2D) . In addition, the number of PLD1-positive cardiomyocytes decreased gradually from postnatal days 21 to 49 (Fig. 2) . Phospholipase D shows dynamic, highly specific expression patterns during tissue development [12] . This study confirmed the differential expression of PLD isozymes in the heart during development in rats. The immunoblot analysis detected only PLD1 in the rat heart, and not PLD2.
During development of the rat heart, signaling pathways must regulate a precise balance among cell survival, proliferation, differentiation, and hypertrophy [4, 7, 14, 16, 18] . The level of PLD1 protein increased transiently at days 0 and 3 postpartum, and declined gradually beginning 7 days after birth. This suggests that PLD1 has an important role in early heart development. Soon after birth, cardiac myocytes lose their ability to proliferate, although the mass of the heart increases continuously [2, 14] . A rapid transition from hyperplastic to hypertrophic myocyte growth occurs between days 3 and 4 in rat heart development [9] . In this study, PLD1 protein was observed from embryonic day 17 to postnatal day 3, which is the myocyte hyperplastic growth period, and then decreased gradually during the myocyte hypertrophic growth period. Furthermore, in the rat hearts, PLD related-signaling proteins and enzymes, such as PKCα expression and the DG concentration, declined beginning 5 and 7 days after birth, respectively, [5] ; those activities are largely consistent with the PLD1 immunoreactivity. In myocytes, PLD1 is also associated with actin rearrangements and myoblast differentiation [8] . Therefore, the increase in PLD1 protein during development may contribute markedly to the proliferation and differentiation of cardiomyocytes.
Furthermore, PLD1 decreased significantly beginning 7 days after birth, and PLD2 was not detected. Cardiomyocytes are linked to hypertrophic growth in this period [9] , suggesting that both PLD1 and PLD2 have minimal involvement in hypertrophic growth during normal cardiac development.
In summary, the rat heart expresses various proteins and enzymes in an age-specific manner, and they may have distinct physical and biochemical roles during postnatal development [4, 7, 16, 18] . The transient expression of PLD1 in the heart occurs from postnatal days 0 to 3, and the PLD1 immunoreactivity is localized in cardiomyocytes. These results suggest that the cardiac expression of PLD1 is closely related to the proliferation and differentiation of myocytes in the heart during early postnatal development.
